Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries
- 1 June 1980
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 19 (6), 907-916
- https://doi.org/10.1016/0090-6980(80)90125-2
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Hypotensive and renovascular actions of 6-keto-prostaglandin E1, a metabolite of prostacyclinEuropean Journal of Pharmacology, 1979
- RECIRCULATION OF PROSTACYCLIN (PGI2) IN THE DOGBritish Journal of Pharmacology, 1978
- Chemical stability of prostacyclin (PGI2) in aqueous solutionsProstaglandins, 1978
- Circulatory and anti-platelet effects of intravenous prostacyclin in healthy menPharmacological Research Communications, 1978
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- Evidence for the presence of a prostaglandin E2-9-keto reductase in rat organsBiochemical and Biophysical Research Communications, 1973